Latest

Private equity owners explore Nemera sale after GLP-1 device demand surge
Astorg and Montagu evaluate exit from drug delivery device maker Nemera, potentially valuing the company at €3 billion. Advisory process to begin in coming months.

German stocks rise as Ifo data signals economic rebound
Dax gains 0.61% to 26,266.14 as business climate improves beyond expectations. Oil and gas prices fall, lifting broader market sentiment.

Swiss Market Index rises 0.54% as ABB, Swisscom lead gains; Amrize hits record low
The SMI advanced to 14,525 points, supported by eurozone data and falling oil prices, while Amrize tumbled to an all-time low after another CFO departure. Swisscom, ABB and Sika led sector gains.

US stocks rise as chip giants Nvidia, Micron gain; Dow pares gains
Nvidia and Micron led gains in U.S. equities as chip stocks rebounded ahead of earnings, while the Dow Jones pared early gains. Swiss SMI advanced on ABB and Sika strength.

VW’s Blume says half of planned job cuts must be in Germany
Volkswagen CEO Oliver Blume told staff that roughly half of up to 50,000 additional global layoffs would occur in Germany as part of a cost-cutting drive. The plan aims to slash €10 billion in overheads amid weak China demand and unused capacity.

Feintool returns to profit as India expansion gains momentum
Swiss industrial components maker posts CHF 3.2 million net income in H1 2026, with EBITDA up 47% and U.S. e-motor cores production slated for November 2026.

UBS ranks Switzerland’s most desirable residential locations
UBS study finds medium-sized Swiss cities outperform large urban centers on cost and livability, with Freiburg, Solothurn and Aarau leading in affordability. Nine of ten regions favor mid-sized towns over metropolises.

Partners Group Private Equity NAV drops 8.6% in H1 2026 as four assets weigh
Net asset value fell to EUR 11.57 per share as USIC, Emeria, Pharmathen and Ammega weighed on returns, though distributions remained robust at EUR 111 million.

US, Swiss stocks rise as chip shares rebound; Nestlé, ABB gain
US benchmarks advance 0.4%-0.6% as Intel, Micron rebound; SMI up 0.21% with ABB, Logitech leading. Nvidia earnings due Wednesday drive tech gains.

Dermapharm posts 14% H1 EBITDA growth as shares rise 1.8%
German pharma group reports 5% revenue growth and 11% earnings rise in first half of 2026, lifts outlook amid strong branded product momentum.

US stock futures rise on tech bets; Nvidia earnings in focus
Dow, Nasdaq seen opening higher as chip stocks rebound; Swiss SMI gains 0.21% led by ABB and Logitech. Oil slips, Bitcoin tops $80,000.

DAX edges up 0.1% as oil slide eases inflation concerns
German blue-chip index nears record high after softer oil prices and upbeat economic signals, while SAP drops nearly 3% on UBS downgrade. Nvidia earnings loom as key U.S. catalyst.

Amrize CFO exits after five months as shares hit record low
Sam Poletti named successor to Baris Oran at struggling Swiss building materials group after shares breach key support. Investor pressure mounts amid inflation and margin concerns.
German DAX rises 0.8% as Ifo data fuels growth hopes
German business sentiment improved more than expected in August, lifting the DAX to within 260 points of its record high. Oil prices eased on geopolitical tensions, while chipmakers and Siemens Energy led gains.

Swiss SMI edges up 0.12% as Roche, Novartis weigh on blue chips
Amrize and Holcim lead gains in the SMI, while Stadler Rail surges 22% on strong half-year results. US PCE inflation ticks up to 3.7%, lifting September Fed hike odds to 40%.

VP Bank reports 1.4 bln CHF net new money inflow in H1, eyes Asia expansion
CEO Urs Monstein outlines turnaround progress, with net new money at 1.4 bln CHF in the first half and a focus on cost discipline, Asian growth and potential acquisitions. Cost/income ratio falls to 78.8%.

Swiss changes in September: Gotthard tunnel closures, dog bans and wage hikes
Switzerland implements new regulations including Gotthard tunnel night closures, a dog ban in Schwyz offices, Basel-Stadt wage increases, and revised federal prosecutorial rules. Ebookers halts Swiss bookings.

German growth surprise, cheaper oil lift European stocks
DAX gains nearly 1% as GDP beats expectations; Brent and WTI oil drop 3% on easing Iran tensions. Siemens Energy shares rise on unit spin-off plans.

Ligand Pharmaceuticals posts 34% revenue rise, raises 2024 EPS guidance
Royalty-focused biotech reports Q2 results and outlines growth strategy at Midwest IDEAS Conference. Shares up 76% over past year.

TWG working with regulators to cut affiliated insurance assets
Group 1001's insurers face scrutiny over related-party investments; TWG plans $6.5 billion swap to reduce exposure. Mark Walter denies fraud allegations.

U.S. core PCE inflation holds at 3.3% in July, matching forecasts
Analysts see sticky services inflation as a key risk, with Fed policy focus shifting to Jackson Hole and September FOMC meeting. Consumer spending growth adjusted for inflation flat.

HPE shares seen swinging 10% on Sept. 2 earnings after options surge
Options pricing signals a potential 10% move for Hewlett Packard Enterprise shares when the company reports third-quarter results after the market close on Sept. 2. Historical data shows mixed alignment between implied and actual volatility.

Leonteq nominates Casutt as chairman, Suter to board ahead of Sept AGM
Casutt, a former Siegfried Holding AG chairman, to succeed Chambers as president; Suter, ex-CFO of Siegfried, joins board. AGM set for Sept 21.

Partners Group PE NAV falls 8.6% in H1 2026 as distributions rise
Private equity investor’s net asset value declined amid portfolio write-downs, though strong investor payouts and selective deployments provided partial offset. Shares trade at a 38.8% discount to NAV.

